Top

BMC Pregnancy and Childbirth

Published in:

01-12-2020 | Research article

Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis

Authors: Lydia Hawker, Andrew Weeks

Published in: BMC Pregnancy and Childbirth | Issue 1/2020

Abstract

Background

Postpartum haemorrhage (PPH) remains a leading cause of maternal mortality. Many trials assessing interventions to prevent PPH base their data on low risk women. It is important to consider the impact data collection methods may have on these results. This review aims to assess trials of PPH prophylaxis by grading trials according to the degree of risk status of the population enrolled in these trials and identify differences in the PPH rates of low risk and high risk populations.

Methods

Systematic review and meta-analysis using a random-effects model. Trials were identified through CENTRAL. Trials were assessed for eligibility then graded according to antenatal risk factors and method of birth into five grades. The main outcomes were overall trial rate of minor PPH (blood loss ≥500 ml) and major PPH (> 1000 ml) and method of determining blood loss (estimated/measured).

Results

There was no relationship between minor or major PPH rate and risk grade (Kruskal-Wallis: minor - T = 0.92, p = 0.82; major - T = 0.91, p = 0.92). There was no difference in minor or major PPH rates when comparing estimation or measurement methods (Mann-Whitney: minor - U = 67, p = 0.75; major - U = 35, p = 0.72). There was however a correlation between % operative births and minor PPH rate, but not major PPH (Spearman r = 0.32 v. Spearman r = 0.098).

Conclusions

Using data from trials using low risk women to generalise best practice guidelines might not be appropriate for all births, particularly complex births. Although complex births contribute disproportionately to PPH rates, this review showed they are often underrepresented in trials. Despite this, there was no difference in reported PPH rates between studies conducted in high and low risk groups. Method of birth was shown to be an important risk factor for minor PPH and may be a better predictor of PPH than antenatal risk factors. Women with operative births are often excluded from trials meaning a lack of data supporting interventions in these women. More focus on complex births is needed to ensure the evidence base is relevant to the target population.

Available only for authorised users

Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):323–33.CrossRef

Mavrides EAS, Chandraharan E, Collins P, Green L, Hunt BJ, Riris S, Thomson AJ. On behalf of the Royal College of Obstetricians and Gynaecologists Prevention and management of postpartum haemorrhage. BJOG Int J Obstet Gynaecol. 2016;124:e106–e49.

NICE. Intrapartum Care: Care of Healthy Women and their Babies during Childbirth. NICE. Clinical Guideline 190. London; 2014.

Weeks A, Neilson J. Rethinking our approach to postpartum haemorrhage and uterotonics. BMJ (Online). 2015;351.

Green L, Knight M, Seeney FM, Hopkinson C, Collins PW, Collis RE, et al. The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study. BJOG Int J Obstet Gynaecol. 2016;123(13):2164–70.CrossRef

Hancock A, Weeks AD, Lavender DT. Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. 2015;15:230.CrossRef

Higgins J, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration 2011;Version 5.1.0 [updated March 2011].

de Haas S, Ghossein-Doha C, van Kuijk SM, van Drongelen J, Spaanderman ME. Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49(2):177–87.CrossRef

Jackson KW Jr, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol. 2001;185(4):873–7.CrossRef

10.

Davies GA, Tessier JL, Woodman MC, Lipson A, Hahn PM. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2005;105(2):294–9.CrossRef

11.

Diop A, Daff B, Sow M, Blum J, Diagne M, Sloan NL, et al. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial. Lancet Glob Health. 2016;4(1):e37–44.CrossRef

12.

Güngördük K, Asicioglu O, Besimoglu B, Güngördük OC, Yildirm G, Ark C, et al. Using Intraumbilical vein injection of oxytocin in routine practice with active Management of the Third Stage of labor: a randomized controlled trial. Obstet Gynecol. 2010;116(3):619–24.CrossRef

13.

Hofmeyr GJ, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, et al. Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor. Int J Gynaecol Obstet. 2011;112(2):98–102.CrossRef

14.

Khan GQ, John IS, Chan T, Wani S, Hughes AO, Stirrat GM. Abu Dhabi third stage trial: oxytocin versus Syntometrine in the active management of the third stage of labour. Eur J Obstet Gynecol Reprod Biol. 1995;58(2):147–51.CrossRef

15.

Lamont RF, Morgan DJ, Logue M, Gordon H. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage. Prostaglandins Other Lipid Mediat. 2001;66(3):203–10.CrossRef

16.

Masuzawa Y, Kataoka Y, Nakamura S, Yaju Y. Cooling the lower abdomen to reduce postpartum blood loss: a randomized controlled trial. PLoS One. 2017;12(10):e0186365.CrossRef

17.

Miller S, Tudor C, Thorsten V. Nyima, Kalyang, Sonam, et al. Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet. J Midwifery Womens Health. 2009;54(2):133–41.e1.CrossRef

18.

Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, Shirdel M. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Aust N Z J Obstet Gynaecol. 2015;55(1):53–8.CrossRef

19.

Priya GP, Veena P, Chaturvedula L, Subitha L. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage. Arch Gynecol Obstet. 2015;292(6):1231–7.CrossRef

20.

Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, et al. Active Management of the Third Stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage: a randomized controlled trial. Obstet Gynecol. 2016;128(4):805–11.CrossRef

21.

Raghavan S, Geller S, Miller S, Goudar S, Anger H, Yadavannavar M, et al. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial. BJOG Int J Obstet Gynaecol. 2016;123(1):120–7.CrossRef

22.

Shady NW, Sallam HF, Elsayed AH, Abdelkader AM, Ali SS, Alanwar A, et al. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial. J Matern Fetal Neonatal Med. 2017:1–7.

23.

Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A, et al. Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2012;119(2 Pt 1):293–300.CrossRef

24.

Ezeama CO, Eleje GU, Ezeama NN, Igwegbe AO, Ikechebelu JI, Ugboaja JO, et al. A comparison of prophylactic intramuscular ergometrine and oxytocin for women in the third stage of labor. Int J Gynaecol Obstet. 2014;124(1):67–71.CrossRef

25.

McDonald SJ, Prendiville WJ, Blair E. Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour. Br Med J. 1993;307(6913):1167–71.CrossRef

26.

Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG Int J Obstet Gynaecol. 2011;118(3):353–61.CrossRef

27.

Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2009;105(3):244–7.CrossRef

28.

Orji E, Agwu F, Loto O, Olaleye O. A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor. Int J Gynaecol Obstet. 2008;101(2):129–32.CrossRef

29.

Vaid A, Dadhwal V, Mittal S, Deka D, Misra R, Sharma JB, et al. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor. Arch Gynecol Obstet. 2009;280(6):893–7.CrossRef

30.

Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev 2018(12):Art No.: CD011689. DOI: https://doi.org/10.1002/14651858.CD011689.pub3.

31.

Althabe F, Alemán A, Tomasso G, Gibbons L, Vitureira G, Belizán JM, et al. A pilot randomized controlled trial of controlled cord traction to reduce postpartum blood loss. Int J Gynaecol Obstet. 2009;107(1):4–7.CrossRef

32.

Deneux-Tharaux C, Sentilhes L, Maillard F, Closset E, Vardon D, Lepercq J, et al. Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR). Br Med J. 2013;346:f1541.CrossRef

33.

Hofmeyr GJ, Mshweshwe NT, Gülmezoglu AM. Controlled cord traction for the third stage of labour. Cochrane Database Syst Rev 2015(1):Art. No.: CD008020. DOI: https://doi.org/10.1002/14651858.CD008020.pub.

34.

Oladapo OT, Okusanya BO, Abalos E. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev 2018(9):Art. No.: CD009332. DOI: https://doi.org/10.1002/14651858.CD009332.pub3.

35.

Dagdeviren H, Cengiz H, Heydarova U, Caypinar SS, Kanawati A, Guven E, et al. Intramuscular versus intravenous prophylactic oxytocin for postpartum hemorrhage after vaginal delivery: a randomized controlled study. Arch Gynecol Obstet. 2016;294(5):911–6.CrossRef

36.

Soltani H, Hutchon DR, Poulose TA. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane Database Syst Rev 2010(8):Art. No.: CD006173. DOI: https://doi.org/10.1002/14651858.CD006173.pub2.

37.

Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev 2013(10):Art. No.: CD001808. DOI: https://doi.org/10.1002/14651858.CD001808.pub2.

38.

Poeschmann R, Doesburg W, Eskes T. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. BJOG Int J Obstet Gynaecol. 1991;98(6):528–30.CrossRef

39.

Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C, Adiibokah E, et al. Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, Cluster-Randomized Trial. PLoS Med. 2013;10(10):e1001524.CrossRef

40.

Pantoja T, Abalos E, Chapman E, Vera C, Serrano VP. Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings. Cochrane Database Syst Rev 2016(4):Art. No.: CD011491. DOI: https://doi.org/10.1002/14651858.CD011491.pub2.

41.

Rogers J, Wood J, McCandlish R, Ayers S, Truesdale A, Elbourne D. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet. 1998;351(9104):693–9.CrossRef

42.

Prendiville WJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active versus physiological management of third stage of labour. Br Med J. 1988;297(6659):1295.CrossRef

43.

Begley CM, Gyte GML, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev 2015(3):Art No.: CD007412. DOI: https://doi.org/10.1002/14651858.CD007412.pub4.

44.

de Groot AN, van Roosmalen J, van Dongen PW, Borm GF. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstetrica et Gynecologica Scandanavica. 1996;75(5):464–8.CrossRef

45.

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev 2018(6):Art. No.: CD005456. DOI: https://doi.org/10.1002/14651858.CD005456.pub3.

46.

Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG Int J Obstet Gynaecol. 2010;117(8):929–36.CrossRef

47.

Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012(4):Art. No.: CD005457. DOI: https://doi.org/10.1002/14651858.CD005457.pub4.

48.

Bais JMJ, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women: a Dutch population-based cohort study on standard (≥500 ml) and severe (≥1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol. 2004;115(2):166–72.PubMed

49.

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2014(2):Art. No.: CD003249. DOI: https://doi.org/10.1002/14651858.CD003249.pub3.

50.

Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003–05. BJOG Int J Obstet Gynaecol. 2007;114(11):1388–96.CrossRef

51.

Larsson C, Saltvedt S, Wiklund I, Pahlen S, Andolf E. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand. 2006;85(12):1448–52.CrossRef

52.

Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS One. 2012;7(7):e41114.CrossRef

53.

Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle M-H, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the international postpartum hemorrhage collaborative group. BMC Pregnancy and Childbirth. 2009;9(1):55.CrossRef

Title: Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis
Authors: Lydia Hawker
Andrew Weeks
Publication date: 01-12-2020
Publisher: BioMed Central
Published in: BMC Pregnancy and Childbirth / Issue 1/2020
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-020-2719-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

“Midwives do not appreciate pregnant women who come to the maternity with torn and dirty clothing”: institutional delivery and postnatal care in Torit County, South Sudan: a mixed method study

Predictors of Helping Babies Breathe knowledge and skills among nurses in primary health settings in Dodoma region, Tanzania

Bimanual examination for clot evacuation: a retrospective cohort study of women with postpartum haemorrhage after vaginal delivery

First trimester anomaly scan using virtual reality (VR FETUS study): study protocol for a randomized clinical trial

Interventions to improve adherence to antenatal and postnatal care regimens among pregnant women in sub-Saharan Africa: a systematic review

The provision of epidural analgesia during labor according to maternal birthplace: a Norwegian register study